Mechanism of Abnormal Coagulation Induced by Tigecycline in Cancer Patients

• Asıl Yazarlar: Li-Hua Sun (Yazar), Kun-Hao Bai (Yazar), Guo-Yan Wu (Yazar), Xiao-Peng Tian (Yazar), Zhi-Qing Zou (Yazar), Da-Wei Wang (Yazar), Yu-Jun Dai (Yazar), Si-Liang Chen (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Frontiers Media S.A., 2022-07-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Tigecycline is a broad-spectrum active intravenous antibiotic that is active against methicillin-resistant staphylococcus aureus. In Phase 3 and 4 clinical trials, increased all-cause mortality was observed in patients treated with tigecycline compared to patients in the control group. The reason fo...